Abstract:This study aims to develop an in vitro barrier effect test over biomimetic membrane, which is useful to establish the film forming ability of a substance-based medical device (SB-MD). The method contemplates a multiparametric approach including: i ) the measurement of the transmembrane passage of a molecular-like marker over a lipid-impregnated biomimetic membrane (simulating the skin and gastro-intestinal and buccal tissues) by using a static diffusion cell apparatus (Franz cell); and ii ) the evaluation of the integrity of the membrane (colorimetric test). In the first step, a series of lipid-impregnated biomimetic membranes (simulating gastro-intestinal, buccal, and skin tissues) were implemented and their permeability performance validated using model drugs (caffeine and acyclovir) by referring to literature data. As a result, the apparent permeability (P app ) of caffeine over the biomimetic gastro-intestinal membrane (P app = 30.5E-6 cm/s) was roughly comparable to the literature values obtained with Caco-2 cell line membrane (P app = 30.8E-6 cm/s) and with the Franz cell method (P app = 36.2E-6 cm/s). Acyclovir was shown to be a poorly permeable substance both in the literature and experimental data. Following this step, the permeability study was extended to both biomimetic buccal and skin (STRAT-M ® ) membranes: for caffeine, biomimetic gastro-intestinal membrane was the most permeable (P app = 30.5E-6 cm/s), followed by the buccal (P app = 18.2E-6 cm/s) then the skin (P app = 0.5E-6 cm/s) biomimetic membranes. In a second part of the work, the barrier effect test was developed following a similar permeability-like approach. The protocol was designed with the idea of assessing the capacity of a certain product to prevent the passage of caffeine across the biomimetic membrane with respect to a negative and positive control. The untreated membrane was the negative control, while membrane covered with a Vaseline film was the positive. As a last step, the developed barrier effect protocol was applied to an experimental gel-like SB-MD under development for the treatment of aphthae (Aphthae gel, an invented trade name), herein used as a case study. Regarding the results, Aphthae gel reduced the caffeine passage by 60.3%, thus highlighting its effectiveness to form a protective film. Overall, these results provide important knowledge and may pave the way for the use—including for industrial applications—of these simple but effective biomimetic membranes for carrying out high throughput screening necessary to design safe and effective SB-MDs before proceeding further with clinical trials, as requested by the regulations.

Magnesia–zirconia Based Mimetic Biomembrane Chromatography for Predicting Human Drug Absorption

Development of biomimetic Phospholipid membrane chromatography for drug discovery: A comprehensive review

Resetting of cardiac C-fiber endings in the spontaneously hypertensive rat.

Immobilised artificial membrane liquid chromatography vs liposome electrokinetic capillary chromatography: Suitability in drug/bio membrane partitioning studies and effectiveness in the assessment of the passage of drugs through the respiratory mucosa

Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs

Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus.

Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery

Ultramikroskopische Untersuchung der submikroskopischen Räume in Gerüstsubstanzen

Polymer membrane and cell models for drug discovery.

Phospholipid-based Immobilized Artificial Membrane (IAM) Chromatography: A Powerful Tool to Model Drug Distribution Processes.

Safety and efficacy of substance-based medical devices: Design of an in vitro barrier effect test

Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology

Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs

In Vitro Characterization of the Biomimetic Properties of Poly(dimethylsiloxane) To Simulate Oral Drug Absorption.

A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro.

Spain faces massive decline in population.

The secret of reversed-phase/weak cation exchange retention mechanisms in mixed-mode liquid chromatography applied for small drug molecule analysis

Dealing with Confounding pH-Dependent Surface Charges in Immobilized Artificial Membrane HPLC Columns

Biomimetic reassembled chylomicrons as novel association model for the prediction of lymphatic transportation of highly lipophilic drugs via the oral route.

Ability of biomimetic chromatography and physicochemical systems to predict the skin permeation of neutral compounds. A comparison study

Lipid Biomimetic Models as Simple Yet Complex Tools to Predict Skin Permeation and Drug–Membrane Biophysical Interactions